There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (3)

Short Titles

Short Titles - Senate

Short Titles as Introduced

SARMs Control Act of 2018
Selective Androgen Receptor Modulators Control Act of 2018

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to amend the Controlled Substances Act to more effectively regulate selective androgen receptor modulators, and for other purposes.

Actions Overview (1)

Date Actions Overview
04/24/2018Introduced in Senate

All Actions (1)

Date All Actions
04/24/2018Read twice and referred to the Committee on the Judiciary.
Action By: Senate

Cosponsors (1)

* = Original cosponsor
CosponsorDate Cosponsored
Sen. Whitehouse, Sheldon [D-RI]* 04/24/2018

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
Senate Judiciary04/24/2018 Referred to

No related bill information was received for S.2742.

Subjects (4)

Latest Summary (1)

There is one summary for S.2742. View summaries

Shown Here:
Introduced in Senate (04/24/2018)

Selective Androgen Receptor Modulators Control Act of 2018 or the SARMs Control Act of 2018

This bill amends the Controlled Substances Act (CSA) to add SARMs (selective androgen receptor modulators) to schedule III. A SARM is a synthetic drug or substance that has effects similar to testosterone. A schedule III controlled substance (e.g., an anabolic steroid) has less potential for abuse than a schedule I or II substance, has a currently accepted medical use, and has low or moderate risk of dependence if abused.

The bill also:

  • authorizes, and establishes procedures for, the Drug Enforcement Administration (DEA) to temporarily and permanently add a drug or substance to the definition of a SARM;
  • specifies that a felony drug offense includes an offense related to SARMs; and
  • makes it unlawful to import, export, manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense, a SARM that is not clearly labeled.

The bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to notify the DEA when it determines that a new dietary ingredient in a dietary supplement may contain a SARM or SARM analogue.